BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31038235)

  • 21. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations.
    Tetzlaff MT; Curry JL; Ning J; Sagiv O; Kandl TL; Peng B; Bell D; Routbort M; Hudgens CW; Ivan D; Kim TB; Chen K; Eterovic AK; Shaw K; Prieto VG; Yemelyanova A; Esmaeli B
    Clin Cancer Res; 2019 Feb; 25(4):1280-1290. PubMed ID: 30420449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
    Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
    Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
    Kim HS; Lee H; Shin SJ; Beom SH; Jung M; Bae S; Lee EY; Park KH; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Noh SH; Rha SY; Kim H; Paik S
    Oncotarget; 2017 Jun; 8(24):38389-38398. PubMed ID: 28418920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
    Canino F; Tornincasa A; Bettelli S; Manfredini S; Barbolini M; Moscetti L; Omarini C; Toss A; Tamburrano F; Antonelli G; Baglio F; Belluzzi L; Martinelli G; Natalizio S; Ponzoni O; Dominici M; Piacentini F
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers.
    Vranic S; Stafford P; Palazzo J; Skenderi F; Swensen J; Xiu J; Spetzler D; Gatalica Z
    Clin Breast Cancer; 2020 Aug; 20(4):326-331.e1. PubMed ID: 32197944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors.
    Lee JW; Kim NKD; Lee SH; Cho HW; Ma Y; Ju HY; Yoo KH; Sung KW; Koo HH; Park WY
    PLoS One; 2019; 14(11):e0224227. PubMed ID: 31747416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer.
    Westbrook TC; Hagemann IS; Ley J; Chen K; Palka K; Liu J; Chen L; Oppelt P; Adkins D
    Med Oncol; 2019 Dec; 37(2):12. PubMed ID: 31865465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome.
    Kotoula V; Tsakiri K; Koliou GA; Lazaridis G; Papadopoulou K; Giannoulatou E; Tikas I; Christodoulou C; Chatzopoulos K; Bobos M; Pentheroudakis G; Tsolaki E; Batistatou A; Kotsakis A; Koutras A; Linardou H; Razis E; Res E; Pectasides D; Fountzilas G
    Clin Breast Cancer; 2019 Apr; 19(2):113-125.e4. PubMed ID: 30545790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer.
    Park YH; Shin HT; Jung HH; Choi YL; Ahn T; Park K; Lee A; Do IG; Kim JY; Ahn JS; Park WY; Im YH
    Oncotarget; 2015 Oct; 6(31):32027-38. PubMed ID: 26397225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy.
    Chen H; Luthra R; Routbort MJ; Patel KP; Cabanillas ME; Broaddus RR; Williams MD
    Mol Cancer Ther; 2018 Jul; 17(7):1575-1584. PubMed ID: 29695638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics.
    Synhaeve NE; van den Bent MJ; French PJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Verdijk R; Dirven CMF; Dubbink HJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):126. PubMed ID: 30470264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of the PTCH1 gene predicts recurrence of breast cancer.
    Wang CY; Chang YC; Kuo YL; Lee KT; Chen PS; Cheung CHA; Chang CP; Phan NN; Shen MR; Hsu HP
    Sci Rep; 2019 Nov; 9(1):16359. PubMed ID: 31704974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.
    Harms PW; Hovelson DH; Cani AK; Omata K; Haller MJ; Wang ML; Arps D; Patel RM; Fullen DR; Wang M; Siddiqui J; Andea A; Tomlins SA
    Hum Pathol; 2016 May; 51():25-31. PubMed ID: 27067779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network.
    Battistella M; Balme B; Jullie ML; Zimmermann U; Carlotti A; Crinquette M; Frouin E; Macagno N; Ortonne N; Lamant L; de la Fouchardiere A; Aubriot-Lorton MH; Durand L; Josselin N; Franck F; Chatelain D; Lemasson G; Algros MP; Durlach A; Machet MC; Courville P; Osio A; Seris A; Mortier L; Jouary T; Cribier B;
    Eur J Cancer; 2022 Mar; 163():211-221. PubMed ID: 35090811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer.
    Chae YK; Davis AA; Jain S; Santa-Maria C; Flaum L; Beaubier N; Platanias LC; Gradishar W; Giles FJ; Cristofanilli M
    Mol Cancer Ther; 2017 Jul; 16(7):1412-1420. PubMed ID: 28446639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis.
    Xu S; Moss TJ; Laura Rubin M; Ning J; Eterovic K; Yu H; Jia R; Fan X; Tetzlaff MT; Esmaeli B
    Mod Pathol; 2020 Jul; 33(7):1256-1263. PubMed ID: 31937901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing.
    Li W; Qiu T; Guo L; Ying J
    Cancer Lett; 2017 Dec; 410():92-99. PubMed ID: 28942013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adnexal skin tumors in Zaria, Nigeria.
    Samaila MO
    Ann Afr Med; 2008 Mar; 7(1):6-10. PubMed ID: 18702242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.